Medical device company Intuitive Surgical, Inc. (NASDAQ: ISRG) has reported a decline in first-quarter earnings despite a double-digit growth in revenues, hurt
Johnson & Johnson
-(JNJ)
Get the latest Johnson & Johnson (JNJ) stock news, earnings analysis, earnings conference calls, earnings transcripts from AlphaStreet.
Kimberly-Clark (KMB) Q1 profit drops but beats estimates; revenue up 7%
Consumer products company Kimberly-Clark Corp. (NYSE: KMB) reported stronger-than-expected earnings and revenues for the first quarter of 2022. The company's stock made
Johnson & Johnson (JNJ) Q1 2022 Earnings Call Transcript
Johnson & Johnson (NYSE: JNJ) Q1 2022 earnings call dated Apr. 19, 2022 Corporate Participants: Joseph J. Wolk -- Executive Vice President, Chief Financial
Johnson & Johnson (JNJ) reports Q1 2022 earnings
Johnson & Johnson (NYSE: JNJ) reported first-quarter 2022 financial results before the regular market hours on Tuesday. The pharmaceutical giant reported revenue
Johnson & Johnson (JNJ) Q4 2021 Earnings Call Transcript
Johnson & Johnson (NYSE: JNJ) Q4 2021 earnings call dated Jan. 25, 2022 Corporate Participants: Jessica Moore -- Vice President, Investor Relations Joseph J. Wolk -- Executive
Johnson & Johnson (JNJ) reports Q4 2021 earnings
Johnson & Johnson (NYSE: JNJ) reported fourth-quarter 2021 financial results before the regular market hours on Tuesday. The pharmaceutical giant reported revenue
IPO Alert: Here’s all you need to know about Bausch + Lomb’s market debut
After slowing down in the final weeks of 2021, IPO activity has picked up momentum despite the uncertain economic conditions. Eye care
Johnson & Johnson (JNJ) Q3 2021 Earnings Call Transcript
Johnson & Johnson (NYSE: JNJ) Q3 2021 earnings call dated Oct. 19, 2021 Corporate Participants: Sarah Wood -- Senior Director, Investor Relations Joseph J.
Johnson & Johnson (JNJ) reports Q3 2021 earnings
Johnson & Johnson (NYSE: JNJ) reported third-quarter 2021 financial results before the regular market hours on Tuesday. The pharmaceutical giant reported revenue
Johnson & Johnson (JNJ) Q2 2021 Earnings Call Transcript
Johnson & Johnson (NYSE: JNJ) Q2 2021 earnings call dated Jul. 21, 2021 Corporate Participants: Christopher DelOrefice -- Vice President, Investor Relations Joseph J.
Johnson & Johnson (JNJ) Q2 2021 Earnings Call
Johnson & Johnson (NYSE: JNJ) Q2 2021 earnings call dated Jul. 21, 2021 Corporate Participants: Christopher DelOrefice — Vice President, Investor Relations Joseph J. Wolk — Executive
Johnson & Johnson beats in Q2; raises FY guidance
Johnson & Johnson (NYSE: JNJ) reported second-quarter 2021 financial results before the regular market hours on Wednesday. The pharmaceutical giant reported Q2
Earnings calendar for the week of July 19
Despite strong trading and encouraging news from the labor market, benchmark stock indexes pulled back after making modest gains early in the
Johnson & Johnson (JNJ) Q1 2021 Earnings Call
Johnson & Johnson (NYSE: JNJ) Q1 2021 earnings call dated Apr. 20, 2021 Corporate Participants: Christopher DelOrefice — Vice President of Investor Relations Joseph J. Wolk — Executive Vice
Johnson & Johnson (JNJ) Q1 2021 Earnings Call Transcript
Johnson & Johnson (NYSE: JNJ) Q1 2021 earnings call dated Apr. 20, 2021 Corporate Participants: Christopher DelOrefice -- Vice President of Investor Relations Joseph
Johnson & Johnson (JNJ) reports Q1 2021 earnings
Johnson & Johnson (NYSE: JNJ) reported first-quarter 2021 financial results before the regular market hours on Tuesday. The pharmaceutical giant reported revenue
Earnings calendar for the week of April 19
The market rally gathered pace this week amid impressive quarterly results, led by the banking sector, and positive economic data. Leading stock
What’s happening on the COVID-19 front? Here are a few updates.
Right about this time last year, the COVID-19 pandemic took over the world with full force as several countries went into complete
Where do these companies stand in the COVID-19 vaccine race?
After the struggle with the COVID-19 pandemic and its impacts clouding most of 2020, the rollout of vaccines against COVID-19 is the
Johnson & Johnson’s (JNJ) single-dose vaccine is effective but lags behind rivals
Johnson & Johnson (NYSE: JNJ) is the latest pharma company to provide results from the trial of its COVID-19 vaccine candidate. The company
Johnson & Johnson (JNJ) Q4 2020 Earnings Call Transcript
Johnson & Johnson (NYSE: JNJ) Q4 2020 earnings call dated Jan. 26, 2021. Corporate Participants: Chris DelOrefice — Vice President, Investor Relations Alex Gorsky — Chairman